Table 6.
Assay Quality Control—Cytotoxicity Assay
| Interplate reproducibilitya | Interday reproducibilitya | %CV of negative controls | Z′-factorb (N = 12–36) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Metric | Cells | (+)c | (−)d | (+) | (−) | (+) | (−) | (+) | (−) |
| Nuclei content | HUVEC | S: 0.81 (<0.0001) | S: 0.72 (<0.0001) | S: 0.79 (<0.0001) | S: 0.71 (<0.0001) | 6.4 | 6.6 | 0.73 | 0.55 |
| P: 0.84 (<0.0001) | P: 0.89 (<0.0001) | P: 0.88 (<0.0001) | P: 0.90 (<0.0001) | ||||||
| iPSC-Endoe | S: 0.81 (<0.0001) | S: 0.78 (<0.0001) | S: 0.71 (<0.0001) | S: 0.58 (<0.0001) | 14.4 | 7.4 | −1.2 | −0.19 | |
| P: 0.83 (<0.0001) | P: 0.89 (<0.0001) | P: 0.77 (<0.0001) | P: 0.80 (<0.0001) | ||||||
| Viable cell staining | HUVEC | S: 0.81 (<0.0001) | S: 0.72 (<0.0001) | S: 0.81 (<0.0001) | S: 0.71 (<0.0001) | 6.4 | 6.6 | 0.78 | 0.80 |
| P: 0.90 (<0.0001) | P: 0.90 (<0.0001) | P: 0.90 (<0.0001) | P: 0.91 (<0.0001) | ||||||
| iPSC-Endoe | S: 0.87 (<0.0001) | S: 0.77 (<0.0001) | S: 0.82 (<0.0001) | S: 0.51 (<0.0001) | 15.4 | 7.4 | 0.53 | 0.64 | |
| P: 0.97 (<0.0001) | P: 0.95 (<0.0001) | P: 0.89 (<0.0001) | P: 0.78 (<0.0001) | ||||||
| ATP content | HUVEC | S: 0.87 (<0.0001) | S: 0.78 (<0.0001) | S: 0.80 (<0.0001) | S: 0.62 (<0.0001) | 6.5 | 6.8 | 0.79 | 0.72 |
| P: 0.91 (<0.0001) | P: 0.89 (<0.0001) | P: 0.86 (<0.0001) | P: 0.91 (<0.0001) | ||||||
| iPSC-Endoe | S: 0.87 (<0.0001) | S: 0.80 (<0.0001) | S: 0.80 (<0.0001) | S: 0.66 (<0.0001) | 8.3 | 7.0 | 0.74 | 0.77 | |
| P: 0.91 (<0.0001) | P: 0.97 (<0.0001) | P: 0.86 (<0.0001) | P: 0.93 (<0.0001) | ||||||
aS: Spearman's ρ, P: Pearson's r. Correlation analysis sample size ranged from n = 96. P values provided below correlation values.
bTreatment with TAB at 50 μM.
c(+): Cells stimulated with cytokines.
d(−): Unstimulated cells.
eiPSC-Endo: iCell endothelial cells from Cellular Dynamics International.
Plots of the data used to calculate Z′-factors shown in this table are included as Supplementary Figure S3.
ATP, adenosine triphosphate.